The Design of a GLP‐1/PYY Dual Acting Agonist
- 15 January 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 133 (15) , 8349-8356
Abstract
The two gut hormones GLP‐1 and PYY3–36, which are both secreted from the L‐cells upon food stimuli, have a stronger inhibitory effect on food intake when they are combined, compared to their individual effects as single agonists. Although they are not homologous and share no sequence similarity, we show that a GLP‐1 analogue can be designed to exhibit potent activity on both the Y2 and GLP‐1 receptors. Dual acting hybrid analogues were realized by designing truncated and potent Y2 receptor PYY analogues, followed by integrating the critical residues into GLP‐1. In this study, we show that one of these dual acting agonists acutely reduces food intake significantly more than the respective mono‐agonist counterparts.Keywords
This publication has 65 references indexed in Scilit:
- The novel GLP ‐1‐gastrin dual agonist, ZP3022 , increases β‐cell mass and prevents diabetes in db/db miceDiabetes, Obesity and Metabolism, 2012
- The Gut Hormones PYY3-36 and GLP-17-36 amide Reduce Food Intake and Modulate Brain Activity in Appetite Centers in HumansCell Metabolism, 2011
- Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion proteinDiabetes/Metabolism Research and Reviews, 2010
- PYY3–36 and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese HumansDiabetes, 2010
- Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 ReceptorJournal of Biological Chemistry, 2010
- A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in miceBioorganic & Medicinal Chemistry Letters, 2007
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36New England Journal of Medicine, 2003
- Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptorFEBS Letters, 1996
- A novel cyclic analog of neuropeptide Y specific for the Y2 receptorEuropean Journal of Biochemistry, 1992
- Highly potent and small neuropeptide Y agonist obtained by linking NPY 1–4 via spacer to α‐helical NPY 25–36FEBS Letters, 1989